-
1
-
-
51649130560
-
-
accessed 2007 May 25
-
American Council on Science and Health. Helping smokers quit: a role for smokeless tobacco? www.acsh.org/publications/pubid.1403/pub_detail.asp (accessed 2007 May 25).
-
Helping smokers quit: A role for smokeless tobacco
-
-
-
2
-
-
51649111305
-
-
Tobacco-Related Disease Research Program, accessed 2007 May 30
-
Tobacco-Related Disease Research Program. Effectiveness of two different regimens in smoking clinic. www.trdrp.org/fundedresearch/Views?Grant_Page.asp? grant_id=1600 (accessed 2007 May 30).
-
Effectiveness of two different regimens in smoking clinic
-
-
-
3
-
-
0036325907
-
Tolerability and safety of sustained-release bupropion in the management of smoking cessation
-
Aubin HJ. Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs. 2002; 62(suppl 2):45-52.
-
(2002)
Drugs
, vol.62
, Issue.SUPPL. 2
, pp. 45-52
-
-
Aubin, H.J.1
-
4
-
-
51649112540
-
-
Zyban (bupropion hydrochloride) package insert. Research Triangle Park, NC: Glaxo Wellcome Inc, 2001 Feb
-
Zyban (bupropion hydrochloride) package insert. Research Triangle Park, NC: Glaxo Wellcome Inc.; 2001 Feb.
-
-
-
-
6
-
-
0033840185
-
Amphetamine positive toxicology screen secondary to bupropion
-
Weintraub D, Linder MW. Amphetamine positive toxicology screen secondary to bupropion. Depress Anxiety. 2000; 12:53-4.
-
(2000)
Depress Anxiety
, vol.12
, pp. 53-54
-
-
Weintraub, D.1
Linder, M.W.2
-
7
-
-
51649124396
-
-
Top 200 prescription drugs of 2005. Pharm Times. 2006; 72:26-30.
-
Top 200 prescription drugs of 2005. Pharm Times. 2006; 72:26-30.
-
-
-
-
8
-
-
51649122836
-
Auditory, nose, and throat disorders
-
Tisdale JE, Miller DA, eds, Bethesda, MD: American Society of Health-System Pharmacists;
-
Blankenship CS. Auditory, nose, and throat disorders. In: Tisdale JE, Miller DA, eds. Drug-induced diseases. Bethesda, MD: American Society of Health-System Pharmacists; 2005:745-57.
-
(2005)
Drug-induced diseases
, pp. 745-757
-
-
Blankenship, C.S.1
-
9
-
-
15244344899
-
Angioedema induced by tramadol - a potentially life-threatening condition
-
Hallberg P, Brenning G. Angioedema induced by tramadol - a potentially life-threatening condition. Eur J Clin Pharmacol. 2005; 60:901-3.
-
(2005)
Eur J Clin Pharmacol
, vol.60
, pp. 901-903
-
-
Hallberg, P.1
Brenning, G.2
-
10
-
-
51649130299
-
Angioedema
-
accessed 2007 May 24
-
Reid M. Angioedema. eMedicine from WebMD. www.emedicine.com/med/topic135. htm (accessed 2007 May 24).
-
eMedicine from WebMD
-
-
Reid, M.1
-
11
-
-
51649100925
-
-
Bupropion. Micromedex healthcare series: Drugdex evaluations. micromedex1/hcs/librarian/ND_PR/Main/PFPUI/AW2CDwc1S12VZV/ND_PG/PRI... (accessed 2007 May 18).
-
Bupropion. Micromedex healthcare series: Drugdex evaluations. micromedex1/hcs/librarian/ND_PR/Main/PFPUI/AW2CDwc1S12VZV/ND_PG/PRI... (accessed 2007 May 18).
-
-
-
-
12
-
-
37349049507
-
-
Top 200 prescription drugs of 2006. Pharm Times. 2007; 73:34-7.
-
Top 200 prescription drugs of 2006. Pharm Times. 2007; 73:34-7.
-
-
-
-
13
-
-
34347380912
-
The pharmacist's role in tobacco cessation: Overview and introduction to the series
-
Hudmon KS. The pharmacist's role in tobacco cessation: overview and introduction to the series. Am J Health-Syst Pharm. 2007; 64:1434-6.
-
(2007)
Am J Health-Syst Pharm
, vol.64
, pp. 1434-1436
-
-
Hudmon, K.S.1
-
14
-
-
51649092905
-
-
Bupropion. Micromedex healthcare series: Poisindex managements. micromedex1/hcs/librarian/ND_PR/Main/PFPUI/AW2CDwc1S11Are/ND_PG/PRIH... (accessed 2007 May 18).
-
Bupropion. Micromedex healthcare series: Poisindex managements. micromedex1/hcs/librarian/ND_PR/Main/PFPUI/AW2CDwc1S11Are/ND_PG/PRIH... (accessed 2007 May 18).
-
-
-
-
16
-
-
51649091550
-
Angioedema
-
accessed 2007 May 24
-
Dodds N. Angioedema. eMedicine from WebMD. www.emedicine.com/emerg/ topic32.htm (accessed 2007 May 24).
-
eMedicine from WebMD
-
-
Dodds, N.1
-
17
-
-
0019799332
-
A method for estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
-
(1981)
Clin Pharmacol Ther
, vol.30
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
|